International law firm Clifford Chance has advised Clayton, Dubilier & Rice (CD&R), the U.S. based private investment firm, on its US$4bn public to privatebid for UDG Healthcare plc (UDG) a leading player in healthcare medical affairs, marketing and advisory services, and in pharma packaging. CD&R intends to combine UDG with Huntsworth, its existing portfolio company acquired in a P2P last year, on which Clifford Chance also advised, to create a set of global solutions to support Pharma and Biotech clients across the life cycle of a drug, from development to launch and beyond patent expiry, across all therapeutic areas.